Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment.
The effect of a pretreatment with phenobarbitone (PB) on the porphyrinogenic action exerted by hexachlorobenzene (HCB) was examined in female rats. Kinetic studies of enzyme function after HCB poisoning showed that porphyrinogen carboxy-lyase was the only enzyme of haem biosynthesis that markedly lowered its activity. Both stages of uroporphyrinogen (UPG) III decarboxylation were decreased. This enzyme, together with UPG I synthase (increased levels) were the first enzymes altered. Subsequently, an increase in delta-aminolaevulinate (AmLev) synthase and ferrochelatase was detected; AmLev dehydratase was the last to increase. On long-term exposure, PB alone did not modify the basal values of haem intermediates; only the content of cytochrome P-450 increased. All the enzyme activities studied showed no significant changes, except ferrochelatase, which increased. With both drugs the metabolic impairment promoted by HCB was accelerated and enhanced by prior PB treatment leading to the onset of an earlier and stronger porphyria. A more noticeable accumulation and excretion of higher carboxylated porphyrins and precursors was more promptly observed as a consequence of the early porphyrinogen carboxy-lyase blockade and the concomitant induction of AmLev synthase. Although the enzymic activities of both AmLev dehydratase and ferrochelatase were enhanced, this response differed in time. For UPG I synthase this pretreatment elicited lower values than those found in the HCB group. Cytochrome P-450 contents were immediately and slightly enhanced by all the drugs, but the values for the combined treatment were the lowest. Of the several hypotheses that could explain the action of HCB on the haem pathway, our results would suggest that the porphyrinogenic action of HCB is mediated by some of its metabolic products.
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism; D002722:Chlorobenzenes / Q000633:toxicity*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D005294:Ferrochelatase / Q000378:metabolism; D006581:Hexachlorobenzene / Q000633:toxicity*; D011163:Hydroxymethylbilane Synthase / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010634:Phenobarbital / Q000494:pharmacology*; D000623:Porphobilinogen Synthase / Q000378:metabolism; D011164:Porphyrias / Q000139:chemically induced* / Q000378:metabolism; D011166:Porphyrins / Q000652:urine; D051381:Rats; D011919:Rats, Inbred Strains
D002722:Chlorobenzenes; D011166:Porphyrins; D006581:Hexachlorobenzene; D003577:Cytochrome P-450 Enzyme System; D000624:5-Aminolevulinate Synthetase; D011163:Hydroxymethylbilane Synthase; D002262:Carboxy-Lyases; C022430:porphyrinogen carboxy-lyase; D000623:Porphobilinogen Synthase; D005294:Ferrochelatase; D010634:Phenobarbital